Last Price
2.18
Today's Change
-0.07 (3.11%)
Day's Change
2.12 - 2.34
Trading Volume
53,387
Market Cap
5 Million
Shares Outstanding
2 Million
Avg Volume
285,667
Avg Price (50 Days)
4.11
Avg Price (200 Days)
6.67
PE Ratio
-0.32
EPS
-6.74
Earnings Announcement
26-Feb-2025
Previous Close
2.25
Open
2.12
Day's Range
2.12 - 2.345
Year Range
2.11 - 24.32
Trading Volume
53,387
1 Day Change
-3.11%
5 Day Change
-33.94%
1 Month Change
-47.47%
3 Month Change
-58.24%
6 Month Change
-57.34%
Ytd Change
-90.73%
1 Year Change
-88.29%
3 Year Change
-95.99%
5 Year Change
-98.11%
10 Year Change
-98.11%
Max Change
-98.11%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.